Purpose Our objective was to investigate whether selfreported obstructive sleep apnea (OSA), simple snoring, and various markers of sleep-disordered breathing (SDB) are associated with cardiovascular risk. Methods We examined a representative nationwide cohort of 5177 Finnish adults aged ≥30 years. The participants underwent measurement of traditional cardiovascular risk factors and answered SDB-related questions derived from the Basic Nordic Sleep Questionnaire, which were used to operationalize self-reported OSA. The primary end point was incidence of a cardiovascular event (cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, hospitalization for heart failure, or coronary interventions). Results During a median follow-up of 11.2 years and 52,910 person-years of follow-up, 634 participants suffered a cardiovascular event. In multivariable-adjusted Cox models, selfreported OSA (hazard ratio [HR] 1.34; 95 % confidence interval [CI] 1.04-1.73; p=0.03) was an independent predictor of cardiovascular events. Self-reported simple snoring by itself was not associated with future cardiovascular events (HR 0.88 versus non-snorers, 95 % CI 0.75-1.04, p=0.15). However, among snorers (n=3152), frequent breathing cessations (HR 2.19, 95 % CI 1.26-3.81, p=0.006) and very loud and irregular snoring (HR 1.82, 95 % CI 1.31-2.54, p<0.001) were associated with cardiovascular risk. Conclusions Self-reported OSA and SDB-related snoring variables are associated with cardiovascular risk, whereas simple snoring is not. In clinical practice and in surveys, questions concerning only habitual snoring should be amended with questions focusing on respiratory pauses and snoring stertorousness, which can be used to estimate the risk of OSA and cardiovascular events.
Introduction
The value of self-reported sleep disordered breathing (SDB) as a cardiovascular risk factor remains unclear. Several lines of evidence, including prospective studies, have shown that polysomnographically diagnosed obstructive sleep apnea (OSA) is a causal risk factor for hypertension [1, 2] , metabolic syndrome [3] , and other cardiovascular manifestations [4] such as stroke [5, 6] , coronary artery disease [7] , and cardiovascular mortality [8] [9] [10] . Polysomnography, however, is a cumbersome and costly examination. In clinical practice, as well as in epidemiological studies, there is a need to use subjective markers of SDB as a first approach in estimating the probability of OSA.
Snoring has been shown to correlate moderately with the apnea-hypopnea [11] and the respiratory disturbance [12] indices. In spite of the somewhat unclear relationships between Teemu J. Niiranen and Erkki Kronholm contributed equally to this work.
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snoring and apnea-hypopnea index or OSA [11] , self-reported snoring is often used in epidemiological studies as a marker of OSA and SDB. In these studies, the associations of selfreported snoring with cardiovascular outcomes have been mixed. Several studies have suggested that self-reported snoring is associated with increased risk of incident hypertension [13] , metabolic syndrome [14] and type 2 diabetes [15] in women, and with incident cardiovascular disease [16] [17] [18] in both genders. However, recent studies with negative results [19, 10, 12] have initiated a new discussion [20] [21] [22] on whether self-reported snoring is truly associated with cardiovascular morbidity and mortality independently of OSA.
One reason underlying these mixed results may be in the differences in phrasing of the snoring-related questions, as snoring can reflect various SDB-related phenomena. Importantly, not all snorers have OSA [11] as portable home recordings have revealed that individuals with no OSA may snore to some extent more than 80 % of the night [12] . Consequently, it would be of interest to study the association between cardiovascular disease and not only simple snoring but also other various self-reported SDB variables, such as the frequency, loudness (stertorousness), and regularity of snoring as well as the presence of respiratory pauses. If the associations between these self-reported SDB variables and cardiovascular outcome differ from each other, this information could be used to improve clinical interviews and epidemiological questionnaires to optimize cardiovascular risk prediction.
The objective of our study was therefore to study if various self-reported SDB variables differ in association with cardiovascular morbidity and mortality in a large-scale, unselected, nationwide prospective cohort. We also examined whether self-reported OSA, operationalized with a series of selfreported SDB variables, would predict cardiovascular outcome. We hypothesized that simple snoring is mainly harmless, but habitual, stertorous snoring in association with breathing cessations would increase the risk of cardiovascular morbidity and mortality.
Methods

Study population
The Health 2000 study was a multidisciplinary epidemiological survey, which was carried out in Finland from autumn 2000 to spring 2001. The study population was a stratified random sample of 8028 subjects drawn from the population register to represent Finnish adults aged ≥30 years. The details of stratification and sampling procedures have been reported previously [23] .
Six thousand three hundred fifty-four individuals (79 %) agreed to participate in the interview and health examination. Subjects who had missing health examination or interview data (office blood pressure, body mass index, smoking status; n=60), missing sleep questionnaire data (n=698), or incomplete laboratory values (fasting cholesterol or glucose level; n=50) were excluded. Five hundred fifty-four subjects with prior history of cardiovascular disease (see Outcome variables) were identified from the National Hospital Discharge Register backwards until the year 1969 and were also excluded. After removing subjects with ≥1 exclusion factor, 5177 participants were included in the analyses. The study protocol of the Health 2000 Study was approved by the epidemiology ethics committee of the Helsinki and Uusimaa hospital region, and all of the participants gave signed, informed consent.
Flow of the study
At an initial health interview at the participant's home, information about background, sleep, health, illnesses, and the use of medications were gathered by centrally trained interviewers. The participants underwent a physical examination 1 to 6 weeks later at a local health center. Each participant's height and weight were measured, and fasting blood samples for serum lipids and glucose were taken from the participants. The participants were given the apnea questionnaire after the physical examination, which they were asked to complete and return by mail. Details of the methodology of the project have been published elsewhere [23] .
Self-reported variables of SDB and definition of self-reported OSA Questions derived from the Basic Nordic Sleep Questionnaire [24] were used to operationalize self-reported OSA as in our earlier studies [25, 26] . Based on the Third Edition of the International Classification of Sleep Disorders [27] , the following logic was applied: If the answer to the question "Do you snore when sleeping? (Ask others if you are not sure)" was "no," self-reported OSA was considered excluded. If the answer was "yes" then the following additional questions were presented: (1) "How often do you snore?"; (2) "What does your snoring sound like? (ask others if needed)"; and (3) "Have you noticed (or have others noticed) respiratory pauses when you sleep?." Self-reported OSA was diagnosed if snoring was frequent (at least during 3-5 nights weekly) and either of the following items was positive: (1) snoring is loud and irregular, with occasional respiratory pauses and/or stertorous breathing, or (2) respiratory pauses with a frequency of at least 1-2 nights weekly. In all other cases, self-reported OSA was considered excluded.
Covariates
Self-reported sleep duration was determined by asking the subjects, "How many hours do you sleep in 24 h?" Responses were recorded in full hours. Missing values for sleep duration (n=100) were imputed by age and gender using a regression approach and rounded to the nearest integer. Diabetes mellitus was defined as a fasting serum glucose level of 7.0 mmol/l or greater or the self-reported use of oral hypoglycemic agents or insulin injections, or both. Use of a lipid-lowering medication was defined as a self-reported use of a HMG-CoA reductase inhibitor (statin), fibrate, or nicotinic-acid and its derivatives. Current smoking was defined as a daily use of tobacco products. Body mass index was defined as weight in kilograms divided by squared height in meters.
Outcome variables
Follow-up data were accumulated until December 31, 2011. Morbid events during the follow-up were identified using the National Hospital Discharge Register, which covers all periods of treatment received in all public and private hospitals in Finland. Mortality data was gathered from the nationwide Causes-of-Death Register. Diagnoses are registered in these registers with codes defined in the 10th revision of the International Classification of Diseases (ICD-10). Cardiovascular diagnoses in these registers, used as described below, have been described and validated in detail previously [28] [29] [30] .
Acute non-fatal coronary events were identified with ICD-10 codes I20 to I22 and/or if the participant had underwent percutaneous coronary intervention or coronary artery bypass surgery. For fatal coronary events, ICD-10 codes I20-I25, I46, R96, and R98 were used. Stroke diagnoses in ICD-10 were I60-I61 and I63-I64 (not I63.6). Heart failure diagnoses included ICD-10 codes I50, I110, I130, and I132. Heart failure cases were also identified using the Finnish Drug Reimbursement Register. If the participant was entitled to special reimbursements for the costs of heart failure medications or had purchased furosemide prescribed by a doctor at least three times since 1995, he/she was considered to have a heart failure.
The primary end point was the combination of cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, new onset heart failure, percutaneous coronary intervention, and coronary artery bypass surgery. The secondary endpoints were incident coronary heart disease, stroke, and heart failure. Only the first event was included in the analysis.
Statistical analyses
Variables were compared using the χ 2 test for categorical variables or analysis of variance for continuous variables. We computed direct adjusted Kaplan-Meier survival curves for different groups based on unstratified Cox models [31] . Hazard ratios and 95 % confidence intervals for self-reported OSA and self-reported SDB variables were derived from multivariable-adjusted Cox proportional hazards models. Kaplan-Meier plots were examined to ensure that proportional hazards would be appropriate. The null hypothesis was rejected for values of p<0.05. Statistical analyses were performed using SAS 9.2 software (SAS Institute, Cary, NC). Table 1 shows the baseline characteristics of the study population. Participants with self-reported OSA were older and had a higher prevalence of smoking and diabetes than participants with no self-reported OSA. In addition, they had higher blood pressure and higher total cholesterol (p≤0.001 for all). However, there was no difference in self-reported sleep duration between the two groups (p=0.99).
Results
Self-reported OSA and cardiovascular prognosis
In the overall study population, median follow-up was 11.2 years (5th to 95th percentile interval, 3.3 to 11.3 years). During 52,910 person-years of follow-up, a fatal or non-fatal cardiovascular endpoint occurred in 634 participants (12.0 per 1000 person-years, Table 2 ). Five hundred sixty-two of these events occurred in participants with no self-reported OSA (n=4782, 11.5 per 1000 person-years) and 72 in participants with self-reported OSA (n=395, 18.7 per 1000 person-years). Figure 1 shows the adjusted Kaplan-Meier curve for the composite cardiovascular endpoint by self-reported OSA status. In Cox models adjusted for age, gender, body mass index, smoking status, and sleep duration, there was a significant association of self-reported OSA with incident cardiovascular disease (hazard ratio [HR] , 95 % confidence interval [CI] 1.10-1.83], p=0.007; Table 2 ). This association retained its significance after further adjustment for baseline cholesterol level, diabetes mellitus, and blood pressure (HR 1.34, 95 % CI 1.04-1.73, p=0.03). In addition, when abnormal sleep duration (<6 or ≥9 h of sleep) and excessive alcohol use (≥210 g of pure alcohol per week) were included as covariates in the model, neither one was significantly associated with the composite endpoint whereas self-reported OSA retained its significance.
We also analyzed the vascular specific endpoints with exclusion of only those with a prior history of that particular endpoint in adjusted Cox models (Table 2) . Although there was a non-significant trend for self-reported OSA being a risk factor for coronary events (HR 1.13, 95 % CI 0.80-1.60, p=0.49) and heart failure (HR 1.29, 95 % CI 0.90-1.84, p=0.17), the association was the strongest and significant for stroke (HR 1.65, 95 % CI 1.06-2.57, p=0.03).
Various SDB variables and cardiovascular prognosis
The independent cardiovascular risk associated with various SDB variables was analyzed with adjusted Kaplan-Meier curves (Fig. 2) and adjusted Cox regression models (Table 3) . In contrast to the findings for self-reported OSA, participants who reported simply snoring at least sometimes did not differ in terms of cardiovascular prognosis from those who did not snore at all (Table 3 , HR 0.88, 95 % CI 0.75-1.04, p=0.15). On the other hand, the adjusted survival curves in Fig. 2 showed marked differences in groups by apnea frequency, snoring stertorousness, and snoring frequency among snorers (n=3 152). The hazard ratios for cardiovascular events in the category of snoring frequency, apnea frequency, and snoring stertorousness that had the poorest prognosis in the Cox models are reported in Table 3 . In these analyses, snoring frequency was not associated with incident cardiovascular events (HR 1.44, 95 % CI 0.94-2.23, p=0.10) while breathing cessations (HR 2.19, 95 % CI 1.26-3.82, p=0.006) and snoring stertorousness (HR 1.82, 95 % CI 1.31-2.54, p<0.001) were. The characteristics of the participants in these categories are reported in Table 4 . By and large, participants with increased snoring frequency, apnea frequency, and snoring stertorousness had a poorer cardiovascular risk profile than their counterparts. The hazard ratios for cardiovascular events in all categories of snoring frequency, apnea frequency, and snoring stertorousness are presented in supplementary tables S1, S2, and S3. In general, the cardiovascular risk increased with the degree of self-reported SDB.
Discussion
Self-reported OSA, operationalized from SDB-related questions, is an independent predictor of cardiovascular events, and especially stroke, in the general population. Out of the specific characteristics of snoring, increased breathing cessations and snoring stertorousness seem to be associated with cardiovascular outcome whereas self-reported simple snoring is not. In addition to highlighting the dangers of OSA, our study reached the same conclusion as two previous studies by Marin et al. and Davis et al. [19, 10] -no association could be found between simple snoring and increased cardiovascular risk. Our results are also in line with a recent study with portable home audio recording of snoring, which suggested that snoring as itself is not associated with future cardiovascular events or mortality [12] . On the other hand, some previous studies have found habitual snoring to be associated with a modest increase of incident coronary heart disease and stroke after adjustment for pertinent risk factors among women [18, 16] and men [17] . This discrepancy in results from various studies could be caused by differences in mean age of the study participants or in operationalizations of (self-reported) snoring.
We suggest that the underlying mechanism behind the associations of self-reported variables for SDB and cardiovascular events is OSA and/or other consequences of habitual snoring rather than simple snoring in itself. The role of intermittent hypoxia, usually measured with the apnea-hypopnea index (AHI, the number of periods of obstructed breathing per hour of sleep), has been shown to be independently associated with cardiovascular morbidity and mortality [5] [6] [7] [8] [9] [10] . Repetitive obstructive apneas have been shown to expose the heart and circulation to a cascade of noxious stimuli, such as negative intrathoracic pressure, autonomic dysregulation, platelet activation, oxidative stress, and endothelial dysfunction, that may initiate or contribute to the progression of cardiovascular disorders [32] . Most likely self-reported breathing cessations and stertorous snoring are markers of an increased AHI, associated with a poor cardiovascular prognosis. On the other hand, simple snoring has been shown to have only a weak association with AHI [11] .
Given the expenses and hurdle of full-night polysomnography, it is clear that the use of self-reported markers of OSA and SDB will continue for screening purposes in clinical use and epidemiological studies. The results of our study highlight the need for questionnaire items Fig. 2 Adjusted Kaplan-Meier survival curves for composite cardiovascular events among snorers (n=3152) by apnea frequency, snoring stertorousness, and snoring frequency assessing OSA and SDB to be formulated in a way that maximally captures the information indicating the presence of OSA and increased cardiovascular risk rather than snoring in general. Our results show that, instead of focusing on only snoring in itself, more attention should be focused on snoring stertorousness and frequency of respiratory pauses among snorers.
A strength of this study is the large sample representative of the nationwide adult population living in Finland. Another strength is the relatively long follow-up of the cohort and nationwide coverage of the cardiovascular events based on high-quality register data. However, the small number of events among participants with self-reported OSA prevents from drawing definite conclusions. Lung disease and depression were not included as covariates in the Cox models which could also be a limitation of this study. Furthermore, our data are self-reported and we do not have polysomnographic validation of the self-reported markers of SDB.
Taken together, our results suggest that self-reported markers of SDB such as habitual snoring, breathing cessations, and stertorous and irregular sound are dimensions of snoring which are associated with incident cardiovascular events. Occasional snoring, i.e., simple snoring in general, is not associated with increased cardiovascular risk and may not be a clinically meaningful target for intervention. In clinical practice and in surveys, screening of individuals for suspected OSA should concentrate on the characteristics of snoring. Our study highlights the need to examine the association between 
